Close

World Pharma Today latest Issue August 2018

 

Every issue of our magazine consists of over 100 pages of the latest newsand articles from the pharmaceutical sector. We aim at providing a quality and engaging editorial for our prestigious audience. Contributions for our magazine are sought from professional experts of the sector. We are willing to include you in our editorial mix. The interactive links throughout the magazine lead to additional supporting information to giveour readership a highly informative experience and relevant information at their fingertips.

Standfirst:There is growing awareness of the valuable role that diagnostics can play, both in the early identification and treatment of dangerous or infectious diseases as well as genetic disorders.

Compliance is a serious issue for India’s pharmaceutical manufacturers, distributors, and retailers; due to the complicated nature of the pharmaceutical supply chain. Serialization requires pharmaceutical manufacturers to invest in new technology and adapt their current processes and systems.

What is a biosimilar?
Whereas generic drugs are identical copycats of small-molecule chemical products, biosimilars are only similar to biologic products; innately more complex than chemical products, biologics are large-molecule, organic drugs, subject to natural variability and vulnerability due to climate changes during the manufacturing process, and as such, it is impossible to produce an exact replica of a biologic—hence the adoption of the nomenclature, “biosimilar.”

Every day, the United States loses 116 lives to the opioid epidemic.(1) Pharmacists are asking what can be done to combat the opioid epidemic and treat pain effectively.

CRM, CLM, KAM, Big Data, customer focus, patient centricity… for the last 20 years,buzzwords and concepts have been raining down on the Pharmaceutical Industry, generating a flurry of projects, proof of concepts, pilots and even some successful implementations.

The emergence of regenerative medicine as a viable therapy class has created an urgency  to review and improve upon the current quality systems distribution standards that are employed in support of these therapies.

Contributors

  • Sample avatar

    Arthur Smith

    Global Marketing Manager Videojet Technologies

  • Sample avatar

    Barbara Zupancic

    Director Patient Recruitment and Retention Worldwide Clinical Trials

  • Sample avatar

    Scott Gray

    CEO Clincierge

  • Sample avatar

    GRAHAM REYNOLDS

    VICE PRESIDENT GENERAL MANAGER GLOBAL BIOLOGICS WEST PHARMACEUTICAL SERVICES

  • Sample avatar

    Ariette van Strien

    Chief Commercial Officer Marken

  • Sample avatar

    Chitra Lele

    Chief Scientific Officer Sciformix Corporation

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok